» Articles » PMID: 31355712

Dual PH-sensitive Liposomes with Low PH-triggered Sheddable PEG for Enhanced Tumor-targeted Drug Delivery

Overview
Specialty Biotechnology
Date 2019 Jul 30
PMID 31355712
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

pH-sensitive liposomes (pSL) have emerged as promising nanocarriers due to their endo/lysosome-escape abilities, however, their pH sensitivity is compromised by poly(ethylene glycol) (PEG) coating. This study investigates whether an intracellular PEG-detachment strategy can overcome this PEG dilemma. First, PEG2000 was conjugated with a phospholipid via an acid-labile hydrazide-hydrazone bond (-CO-NH-N = CH-), which was postinserted into pSL, forming PEG-cleavable pSL (CL-PEG-pSL). Their endo/lysosomal-escape abilities in MIA PaCa-2 cells, pharmacokinetics and tumor accumulation abilities were studied using PEG-pSL as reference. CL-PEG-pSL showed rapid endo/lysosome-escape abilities in the cancer cells and higher tumor accumulation in MIA PaCa-2 xenograft model in contrast to PEG-pSL. Cleavable PEGylation is an efficient strategy to ameliorate the PEG dilemma of pSL for cancer drug delivery.

Citing Articles

Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection.

Kim M, Kim J, Rhim W, Cimaglia G, Want A, Morgan J Acta Neuropathol Commun. 2024; 12(1):65.

PMID: 38649962 PMC: 11036688. DOI: 10.1186/s40478-024-01777-0.


TiO/PEG as smart anticorrosion and drug-eluting platforms in inflammatory conditions.

Al-Hawary S, Habash R, Abosaooda M, Hjazi A, Musad Saleh E, Hassan Z Heliyon. 2024; 10(4):e25605.

PMID: 38370200 PMC: 10867653. DOI: 10.1016/j.heliyon.2024.e25605.


Liposomes for the Treatment of Brain Cancer-A Review.

Raju R, Abuwatfa W, Pitt W, Husseini G Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37630971 PMC: 10458450. DOI: 10.3390/ph16081056.


Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review.

Wang T, Wu C, Hu Y, Zhang Y, Ma J RSC Adv. 2023; 13(24):16488-16511.

PMID: 37274408 PMC: 10233443. DOI: 10.1039/d3ra00866e.


Key Design Features of Lipid Nanoparticles and Electrostatic Charge-Based Lipid Nanoparticle Targeting.

Gyanani V, Goswami R Pharmaceutics. 2023; 15(4).

PMID: 37111668 PMC: 10144967. DOI: 10.3390/pharmaceutics15041184.